These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23149436)

  • 1. Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy.
    Zhao Q; Zhang J; Wu T; Li SW; Ng MH; Xia NS; Shih JW
    J Gastroenterol; 2013 Feb; 48(2):159-68. PubMed ID: 23149436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation.
    Li Y; Huang X; Zhang Z; Li S; Zhang J; Xia N; Zhao Q
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31963175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity.
    Zhang J; Li SW; Wu T; Zhao Q; Ng MH; Xia NS
    Rev Med Virol; 2012 Sep; 22(5):339-49. PubMed ID: 22645002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal investigation of rat hepatitis E virus antigenicity: Implications for infection, diagnostics, and vaccine efficacy.
    Sridhar S; Situ J; Cai JP; Yip CC; Wu S; Zhang AJ; Wen L; Chew NF; Chan WM; Poon RW; Chan JF; Tsang DN; Chen H; Xia NS; Yuen KY
    J Hepatol; 2021 Jun; 74(6):1315-1324. PubMed ID: 33845058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel multi-epitope peptide vaccine candidate targeting hepatitis E virus: An in silico approach.
    Kumar A; Sahu U; Agnihotri G; Dixit A; Khare P
    J Viral Hepat; 2024 Aug; 31(8):446-456. PubMed ID: 38727597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis E vaccine development: a 14 year odyssey.
    Wu T; Li SW; Zhang J; Ng MH; Xia NS; Zhao Q
    Hum Vaccin Immunother; 2012 Jun; 8(6):823-7. PubMed ID: 22699438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of new hepatitis E vaccines.
    Cao Y; Bing Z; Guan S; Zhang Z; Wang X
    Hum Vaccin Immunother; 2018; 14(9):2254-2262. PubMed ID: 29708836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hepatitis E virus (HEV) zoonotic transmission: protection of rabbits against HEV challenge following immunization with HEV 239 vaccine.
    Liu P; Du Rj; Wang L; Han J; Liu L; Zhang Yl; Xia Jk; Lu Fm; Zhuang H
    PLoS One; 2014; 9(1):e87600. PubMed ID: 24498149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific memory B cell response and participation of CD4
    Kulkarni SP; Thanapati S; Arankalle VA; Tripathy AS
    Vaccine; 2016 Nov; 34(48):5895-5902. PubMed ID: 27997340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine.
    Purcell RH; Nguyen H; Shapiro M; Engle RE; Govindarajan S; Blackwelder WC; Wong DC; Prieels JP; Emerson SU
    Vaccine; 2003 Jun; 21(19-20):2607-15. PubMed ID: 12744897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs.
    Sanford BJ; Opriessnig T; Kenney SP; Dryman BA; Córdoba L; Meng XJ
    Vaccine; 2012 Sep; 30(44):6249-55. PubMed ID: 22906724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh.
    Zaman K; Dudman S; Stene-Johansen K; Qadri F; Yunus M; Sandbu S; Gurley ES; Overbo J; Julin CH; Dembinski JL; Nahar Q; Rahman A; Bhuiyan TR; Rahman M; Haque W; Khan J; Aziz A; Khanam M; Streatfield PK; Clemens JD
    BMJ Open; 2020 Jan; 10(1):e033702. PubMed ID: 31959609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity against hepatitis E virus infection: Implications for therapy and vaccine development.
    Hakim MS; Ikram A; Zhou J; Wang W; Peppelenbosch MP; Pan Q
    Rev Med Virol; 2018 Mar; 28(2):. PubMed ID: 29272060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of hepatitis E vaccine in elderly people older than 65 years.
    Yu XY; Chen ZP; Wang SY; Pan HR; Wang ZF; Zhang QF; Shen LZ; Zheng XP; Yan CF; Lu M; Chen B; Zheng Y; Zhang J; Lv HK; Huang SJ
    Vaccine; 2019 Jul; 37(32):4581-4586. PubMed ID: 31262585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation in yeast and antigenic characterization of hepatitis E virus capsid protein virus-like particles.
    Simanavicius M; Tamosiunas PL; Petraityte-Burneikiene R; Johne R; Ulrich RG; Zvirbliene A; Kucinskaite-Kodze I
    Appl Microbiol Biotechnol; 2018 Jan; 102(1):185-198. PubMed ID: 29143081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice.
    Deshmukh TM; Lole KS; Tripathy AS; Arankalle VA
    Vaccine; 2007 May; 25(22):4350-60. PubMed ID: 17459540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance Evaluation of Different Commercial Serological Kits for Diagnosis of Acute Hepatitis E Viral Infection.
    Zhang Q; Zong X; Li D; Lin J; Li L
    Pol J Microbiol; 2020 Sep; 69(2):217-222. PubMed ID: 32548990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and efficacy of a bacterially expressed HEV ORF3 peptide, assessed by experimental infection of primates.
    Ma H; Song X; Harrison TJ; Li R; Huang G; Zhang H; Kong W; Wang Y
    Arch Virol; 2009; 154(10):1641-8. PubMed ID: 19763777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity.
    Zhang J; Zhang XF; Zhou C; Wang ZZ; Huang SJ; Yao X; Liang ZL; Wu T; Li JX; Yan Q; Yang CL; Jiang HM; Huang HJ; Xian YL; Shih JW; Ng MH; Li YM; Wang JZ; Zhu FC; Xia NS
    Clin Microbiol Infect; 2014 Jun; 20(6):O397-405. PubMed ID: 24118636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward the development of a hepatitis E vaccine.
    Kamili S
    Virus Res; 2011 Oct; 161(1):93-100. PubMed ID: 21620908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.